Cover Image
Market Research Report

Asia Pacific Pharmaceutical Drug Delivery Market Forecast to 2027 - COVID-19 Impact and Country Analysis By *Route of Administration ; Application ; End User ; and Country

Published by The Insight Partners Product code 943398
Published Content info 146 Pages
Delivery time: 1-2 business days
Price
Back to Top
Asia Pacific Pharmaceutical Drug Delivery Market Forecast to 2027 - COVID-19 Impact and Country Analysis By *Route of Administration ; Application ; End User ; and Country
Published: June 9, 2020 Content info: 146 Pages
Description

Title:
Asia Pacific Pharmaceutical Drug Delivery Market Forecast to 2027 - COVID-19 Impact and Country Analysis By *Route of Administration (Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery, Nasal Drug Delivery, Transmucosal Drug Delivery, Implantable Drug Delivery); Application (Infectious Diseases, Cancer, Cardiovascular Diseases, Diabetes, Respiratory. Diseases, Central Nervous System Disorders, Autoimmune Diseases, and Other Diseases); End User (Hospitals, Home Care Settings, ASC/Clinics, Other End Users); and Country.

The Asia Pacific the pharmaceutical drug delivery market is anticipated to reach US$ 4,73,700.1 Mn by 2027 from US$ 2,77,589.9 Mn in 2019. The market is projected to grow at a CAGR of 7.1% during 2019-2027.

The growth of the pharmaceutical drug delivery market in this region is primarily attributed to the increasing shortage of medicines in various countries. However, the low R&D funding by governments of developing economies hampers the growth of the market. On the other hand, growing emerging markets is expected to have a positive impact on the growth of the Asia Pacific pharmaceutical drug delivery market in the coming years.

Drug delivery systems are medical devices used to inject drugs or therapeutic chemicals into the body. Several types of the drug delivery systems available in the market include transmucosal, oral, pulmonary, injectable, topical, nasal, implantable, and ocular, among others. These systems are enabled with the technologies that are primarily used to have a controlled or targeted delivery of various therapeutic agents for the treatment of multiple diseases.

The shortage of essential medicines and drugs is becoming more frequent issue in Asia Pacific. This is resulting in a burden on the health systems, with additional costs as well as risk to the patients' health. The patients in need of medicines lack access to appropriate doses due to the unavailability of drugs. According to WHO Drug Information 2016, the shortages of essential medicines have been reported from low, middle, and high-income countries. The shortages of medicines as a result of non-treatment, under-treatment, and possible medication errors from attempts to substitute missing medicines.

According to the Food and Drug Administration (FDA), quality-related problems, manufacturing inefficiency and delays, and product discontinuation are among the main reasons that lead to drug shortage. The drugs that are often short in supply include sterile injectable and oncology/cancer therapeutics. The notice from manufacturers to the FDA regarding the impending or current shortages of drugs allows the FDA to work with the manufacturers over finding feasible solutions, one of which is usually ramping up the manufacturing of drugs through the implementation of new and advanced systems. Thus, to meet the rising demand for biologics and drugs as well as to curb the lack of drug availability, the market is expected to hold a promising growth in the coming years in the region.

In 2019, the injectable drug delivery segment accounted for the largest share of the Asia Pacific pharmaceutical drug delivery market, based on the route of administration. However, the topical drug delivery segment is estimated to mark the highest CAGR in the market during the forecast period, owing to the increasing number of patients with skin diseases and a gradual shift of patient preference toward novel, transdermal delivery systems.

A few of the significant primary and secondary sources for pharmaceutical drug delivery included in the report are Chinese Academy of Sciences (CAS), Australian Research Council (ARC), Centers For Disease Control And Prevention (CDC), Food and Drug Administration (FDA), Ministry of Health and Prevention (MoHAP), Ministry of Health and Family Welfare (MoHFW), and among others.

Reasons to Buy

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia Pacific pharmaceutical drug delivery market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific pharmaceutical drug delivery market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth regional market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Table of Contents
Product Code: TIPRE00011593

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Asia Pacific Pharmaceutical Drug Delivery Market - By Route of Administration
    • 1.3.2 Asia Pacific Pharmaceutical Drug Delivery Market - By Application
    • 1.3.3 Asia Pacific Pharmaceutical Drug Delivery Market - By End User
    • 1.3.4 Asia Pacific Pharmaceutical Drug Delivery Market - By Country

2. Asia Pacific Pharmaceutical Drug Delivery Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Asia Pacific Pharmaceutical Drug Delivery Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 4.2.1 Asia Pacific Pharmaceutical Drug Delivery Market - Asia Pacific PEST Analysis
  • 4.3 Expert Opinion

5. Asia Pacific Pharmaceutical Drug Delivery Market - Key Market Dynamics

  • 5.1 Key Market Drivers
    • 5.1.1 Increasing Shortage of Medicines
  • 5.2 Key Restraints
    • 5.2.1 Low R&D Funding by Government in Developing Economies
  • 5.3 Key Market Opportunities
    • 5.3.1 Growing Emerging Markets
  • 5.4 Future Trend
    • 5.4.1 Increasing Popularity of Liposomes in Drug Delivery
  • 5.5 Impact Analysis

6. Pharmaceutical Drug Delivery Market - Asia Pacific Analysis

  • 6.1 Asia Pacific Pharmaceutical Drug Delivery Market Revenue Forecasts and Analysis

7. Pharmaceutical Drug Delivery Market Analysis - By Route of Administration

  • 7.1 Overview
  • 7.2 Asia Pacific Pharmaceutical Drug Delivery Market Revenue Share, by Route of Administration (2019 and 2027)
  • 7.3 Oral Drug Delivery
    • 7.3.1 Overview
    • 7.3.2 Oral Drug Delivery: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • 7.4 Injectable Drug Delivery
    • 7.4.1 Overview
    • 7.4.2 Injectable Drug Delivery: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • 7.5 Topical Drug Delivery
    • 7.5.1 Overview
    • 7.5.2 Topical Drug Delivery: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • 7.6 Ocular Drug Delivery
    • 7.6.1 Overview
    • 7.6.2 Ocular Drug Delivery: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • 7.7 Pulmonary Drug Delivery
    • 7.7.1 Overview
    • 7.7.2 Pulmonary Drug Delivery: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • 7.8 Nasal Drug Delivery
    • 7.8.1 Overview
    • 7.8.2 Nasal Drug Delivery: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • 7.9 Transmucosal Drug Delivery
    • 7.9.1 Overview
    • 7.9.2 Transmucosal Drug Delivery: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • 7.10 Implantable Drug Delivery
    • 7.10.1 Overview
    • 7.10.2 Implantable Drug Delivery: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)

8. Pharmaceutical Drug Delivery Market Analysis - By Application

  • 8.1 Overview
  • 8.2 Asia Pacific Pharmaceutical Drug Delivery Market Revenue Share, by Application (2019 and 2027)
  • 8.3 Infectious Diseases
    • 8.3.1 Overview
    • 8.3.2 Infectious Diseases: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • 8.4 Cancer
    • 8.4.1 Overview
    • 8.4.2 Cancer: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • 8.5 Cardiovascular Diseases
    • 8.5.1 Overview
    • 8.5.2 Cardiovascular Diseases: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • 8.6 Diabetes
    • 8.6.1 Overview
    • 8.6.2 Diabetes: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • 8.7 Respiratory Diseases
    • 8.7.1 Overview
    • 8.7.2 Respiratory Diseases: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • 8.8 Central Nervous System Disorders
    • 8.8.1 Overview
    • 8.8.2 Central Nervous Systems Disorders: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • 8.9 Autoimmune Diseases
    • 8.9.1 Overview
    • 8.9.2 Autoimmune Diseases: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • 8.10 Other Diseases
    • 8.10.1 Overview
    • 8.10.2 Other Diseases: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)

9. Pharmaceutical Drug Delivery Market Analysis - By End User

  • 9.1 Overview
  • 9.2 Asia Pacific Pharmaceutical Drug Delivery Market Share, by End User, 2019 and 2027, (%)
  • 9.3 Hospitals
    • 9.3.1 Overview
    • 9.3.2 Hospitals: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • 9.4 Home Care Settings
    • 9.4.1 Overview
    • 9.4.2 Home Care Settings: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • 9.5 ASCs/ Clinics
    • 9.5.1 Overview
    • 9.5.2 ASCs/ Clinics: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • 9.6 Other End Users
    • 9.6.1 Overview
    • 9.6.2 Other End Users: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)

10. Pharmaceutical Drug Delivery Market Revenue and Forecasts To 2027 - Geographical Analysis

  • 10.1 Asia Pacific Pharmaceutical Drug Delivery Market Revenue and Forecasts To 2027
    • 10.1.1 Overview
    • 10.1.2 Asia Pacific: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
    • 10.1.3 Asia Pacific Pharmaceutical Drug Delivery Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
    • 10.1.4 Asia Pacific Pharmaceutical Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
    • 10.1.5 Asia Pacific Pharmaceutical Drug Delivery Market, by End User - Revenue and Forecast to 2027 (USD Million)
    • 10.1.6 Asia Pacific: Pharmaceutical Drug Delivery Market, by Country, 2019 & 2027 (%)
    • 10.1.7 China: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.7.1 China: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.7.2 China Pharmaceutical Drug Delivery Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
      • 10.1.7.3 China Pharmaceutical Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
      • 10.1.7.4 China Pharmaceutical Drug Delivery Market, by End User - Revenue and Forecast to 2027 (USD Million)
    • 10.1.8 Japan: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.8.1 Japan: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.8.2 Japan Pharmaceutical Drug Delivery Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
      • 10.1.8.3 Japan Pharmaceutical Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
      • 10.1.8.4 Japan Pharmaceutical Drug Delivery Market, by End User - Revenue and Forecast to 2027 (USD Million)
    • 10.1.9 India: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.9.1 India: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.9.2 India Pharmaceutical Drug Delivery Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
      • 10.1.9.3 India Pharmaceutical Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
      • 10.1.9.4 India Pharmaceutical Drug Delivery Market, by End User - Revenue and Forecast to 2027 (USD Million)
    • 10.1.10 South Korea: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.10.1 South Korea: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.10.2 South Korea Pharmaceutical Drug Delivery Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
      • 10.1.10.3 South Korea Pharmaceutical Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
      • 10.1.10.4 South Korea Pharmaceutical Drug Delivery Market, by End User - Revenue and Forecast to 2027 (USD Million)
    • 10.1.11 Australia: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.11.1 Australia: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.11.2 Australia Pharmaceutical Drug Delivery Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
      • 10.1.11.3 Australia Pharmaceutical Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
      • 10.1.11.4 Australia Pharmaceutical Drug Delivery Market, by End User - Revenue and Forecast to 2027 (USD Million)

11. Impact of COVID-19 Pandemic on Global Pharmaceutical Drug Delivery Market

  • 11.1 Asia Pacific: Impact Assessment of COVID-19 Pandemic

12. Company Profiles

  • 12.1 3M
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Antares Pharma
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Bayer AG
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 BD
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 GlaxoSmithKline plc.
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments

13. Appendix

  • 13.1 About The Insight Partners
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. Asia Pacific Pharmaceutical Drug Delivery Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 2. Asia Pacific Pharmaceutical Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 3. Asia Pacific Pharmaceutical Drug Delivery Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 4. China Pharmaceutical Drug Delivery Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 5. China Pharmaceutical Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 6. China Pharmaceutical Drug Delivery Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 7. Japan Pharmaceutical Drug Delivery Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 8. Japan Pharmaceutical Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 9. Japan Pharmaceutical Drug Delivery Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 10. India Pharmaceutical Drug Delivery Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 11. India Pharmaceutical Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 12. India Pharmaceutical Drug Delivery Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 13. South Korea Pharmaceutical Drug Delivery Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 14. South Korea Pharmaceutical Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 15. South Korea Pharmaceutical Drug Delivery Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 16. Australia Pharmaceutical Drug Delivery Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 17. Australia Pharmaceutical Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 18. Australia Pharmaceutical Drug Delivery Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 19. Glossary of Terms, Pharmaceutical Drug Delivery market

List Of Figures

  • Figure 1. Asia Pacific Pharmaceutical Drug Delivery Market Segmentation
  • Figure 2. Asia Pacific Pharmaceutical Drug Delivery Market Overview
  • Figure 3. Injectable Drug Delivery Segment Held Largest Share of Product Segment in Pharmaceutical Drug Delivery Market
  • Figure 4. China Is Expected to Show Remarkable Growth During the Forecast Period
  • Figure 5. Asia Pacific Pharmaceutical Drug Delivery Market- Leading Country Markets (US$ Mn)
  • Figure 6. Asia Pacific Pharmaceutical Drug Delivery Market - Asia Pacific PEST Analysis
  • Figure 7. Asia Pacific Pharmaceutical Drug Delivery Market Impact Analysis of Drivers and Restraints
  • Figure 8. Asia Pacific Pharmaceutical Drug Delivery Market - Revenue Forecasts and Analysis - 2019- 2027
  • Figure 9. Asia Pacific Pharmaceutical Drug Delivery Market Revenue Share, by Route of Administration (2019 and 2027)
  • Figure 10. Oral Drug Delivery: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 11. Injectable Drug Delivery: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 12. Topical Drug Delivery: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 13. Ocular Drug Delivery: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 14. Pulmonary Drug Delivery: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 15. Nasal Drug Delivery: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 16. Transmucosal Drug Delivery: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 17. Implantable Drug Delivery: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 18. Asia Pacific Pharmaceutical Drug Delivery Market Revenue Share, by Application (2019 and 2027)
  • Figure 19. Infectious Diseases: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 20. Cancer: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 21. Cardiovascular Diseases: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 22. Diabetes: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 23. Respiratory Diseases: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 24. Central Nervous Systems Disorders: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 25. Autoimmune Diseases: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 26. Other Diseases: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 27. Asia Pacific Pharmaceutical Drug Delivery Market Share, by End User, 2019 and 2027 (%)
  • Figure 28. Hospitals: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 29. Home Care Settings: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 30. ASCs/ Clinics: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 31. Other End Users: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 32. Asia Pacific: Pharmaceutical Drug Delivery Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 33. Asia Pacific Pharmaceutical Drug Delivery Market Revenue and Forecast to 2027 (USD Million)
  • Figure 34. Asia Pacific: Pharmaceutical Drug Delivery Market, by Country, 2019 & 2027 (%)
  • Figure 35. China: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 36. Japan: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 37. India: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 38. South Korea: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 39. Australia: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 40. Impact of COVID-19 Pandemic in Asia-Pacific Country Markets
Back to Top